Swiss Rock Aktien Europa X

Reference Data

ISIN LU1048648130
Valor Number 25008424
Bloomberg Global ID
Fund Name Swiss Rock Aktien Europa X
Fund Provider Swiss Rock Asset Management AG Zürich, Switzerland
Phone: +41 44 360 57 00
E-Mail: info@swiss-rock.ch
Web: www.swiss-rock.ch
Fund Provider Swiss Rock Asset Management AG
Representative in Switzerland Swiss Rock Asset Management AG
Zürich
Phone: +41 44 360 57 00
Distributor(s) Swiss Rock Asset Management AG
Zürich
Phone: +41 44 360 57 00
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** Top tier performance in european equity with a rock solid investment approach, rotating investment styles.
Peculiarities

Fund Prices

Current Price * 23.99 EUR 22.08.2025
Previous Price * 23.90 EUR 21.08.2025
52 Week High * 23.99 EUR 22.08.2025
52 Week Low * 19.74 EUR 09.04.2025
NAV * 23.99 EUR 22.08.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 47,920,792
Unit/Share Assets *** 1,624,268
Trading Information SIX

Performance

YTD Performance +14.46% 31.12.2024
22.08.2025
YTD Performance (in CHF) +14.44% 31.12.2024
22.08.2025
1 month +3.27% 22.07.2025
22.08.2025
3 months +2.09% 22.05.2025
22.08.2025
6 months +4.67% 24.02.2025
22.08.2025
1 year +13.43% 22.08.2024
22.08.2025
2 years +36.77% 22.08.2023
22.08.2025
3 years +48.27% 22.08.2022
22.08.2025
5 years +83.27% 24.08.2020
22.08.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

SAP SE 3.22%
Novartis AG Registered Shares 2.62%
ASML Holding NV 2.37%
Novo Nordisk AS Class B 2.03%
HSBC Holdings PLC 1.94%
Siemens AG 1.88%
Allianz SE 1.67%
Unilever PLC 1.63%
AstraZeneca PLC 1.56%
Roche Holding AG 1.46%
Last data update 30.04.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee ***
Ongoing Charges *** 0.28%
SRRI ***
SRRI date *** 31.07.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)